Page 3 - வளர பார்மா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வளர பார்மா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வளர பார்மா Today - Breaking & Trending Today

Aphria CEO Hopes Weed Is Fully Legalized in U.S. in 2 to 3 Years, Touts Global Growth Prospects


Simon made the remarks in an interview on Closing Bell alongside Tilray CEO Brendan Kennedy. In December, the Canadian companies announced plans to merge in all-stock deal that would create the biggest cannabis producer by sales in the world.
There s a lot of unknown about what will happen in the U.S. but we ll have the balance sheet, we ll have the knowledge, we ll have the brands, we ll have the technology to be able to make a major impact once legalization happens, Simon said. I say full legalization in the next two to three years.
Simon, who will lead the combined company once the deal closes, added that he s a big believer that legalization may happen in Germany and Portugal and some other countries before the U.S. ....

New Jersey , United States , Ron Wyden , Brendan Kennedy , Irwin Simon , Cory Booker , Phil Murphy , Joe Biden , Senate Majority Leader Chuck Schumer , Sweetwater Brewing Company , Amplify Seymour Cannabis , Democrat Joe , Grow Pharma , Atlanta Based Sweetwater Brewing Company , Tilray Owned Manitoba Harvest , Food And Drink , Health Amp Science , இனிப்பான தண்ணீர் , புதியது ஜெர்சி , ஒன்றுபட்டது மாநிலங்களில் , ரோன் வைடன் , பிரெண்டன் கெந்நெடீ , இர்வின் சிமோன் , கோரி புக்கர் , பில் மர்பி , ஓஹோ பிடென் ,

Tilray Stock Has Shown Lots of Progress, but the Valuation Is Frothy


Tilray Stock Has Shown Lots of Progress, but the Valuation Is Frothy
InvestorPlace
2/22/2021
Ahead of its earnings report,
Tilray (NASDAQ:
TLRY) came under some pressure. Note that TLRY stock fell about 9% or so. Then again, many other cannabis stocks fell as well.
© Provided by InvestorPlace
marijuana stocks Hand gently holding rich soil for his marijuana plants
But volatility is nothing new for Tilray. For the most part, Wall Street liked the performance for the quarter.
Revenues rose by 20.5% to $56.6 million, which compared to the Street consensus of $56 million. The company’s bottom line was also better than expected. The net loss was $2.9 million or 2 cents a share. As for the analysts’ consensus, it was for a net loss of 14 cents a share. ....

Tilray Brendan Kennedy , Irwin Simon , Jetacom Autofocus , Wall Street , Grow Pharma , Worldpharma Biotech , Brendan Kennedy , இர்வின் சிமோன் , சுவர் தெரு , வளர பார்மா , பிரெண்டன் கெந்நெடீ ,